data_1d9a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1d9a _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.293 -0.632 . . . . 2.67 109.293 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.4 63.03 0.71 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 1.34 109.655 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.462 ' O ' HD21 ' A' ' 4' ' ' LEU . 22.8 p30 -86.15 167.82 14.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 1.92 109.225 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.526 HD23 ' CD1' ' A' ' 60' ' ' ILE . 24.2 mt -134.5 157.14 47.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 1.29 109.751 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.623 ' CE2' HG11 ' A' ' 45' ' ' VAL . 20.1 t80 -138.17 94.03 2.83 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.822 -0.807 . . . . 2.64 108.822 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 77' ' ' VAL . 2.6 t -102.02 103.55 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 1.29 109.593 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.458 ' HA ' HG12 ' A' ' 45' ' ' VAL . 6.0 p -101.58 174.19 6.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.311 -0.868 . . . . 1.32 109.628 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 74' ' ' PRO . . . 77.4 30.97 52.9 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.519 -1.433 . . . . 1.23 109.519 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 6' ' ' VAL . 13.7 mt -90.02 155.74 47.09 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 1.63 109.645 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.456 ' HD2' ' SD ' ' A' ' 13' ' ' MET . 36.0 Cg_endo -77.78 171.48 17.29 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.658 2.239 . . . . 1.51 109.964 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -17.37 61.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.91 . . . . 4.26 109.509 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.6 p -79.67 -7.59 58.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.928 . . . . 2.23 109.46 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.513 ' CG ' HD11 ' A' ' 33' ' ' ILE . 3.2 tpt -61.71 103.92 0.38 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.933 . . . . 1.78 109.727 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.519 ' CB ' ' HB2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -91.22 155.2 18.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 2.42 108.986 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.414 ' CD ' ' HG2' ' A' ' 32' ' ' ARG . 12.0 mt-30 -58.57 -56.3 23.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 3.28 109.694 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -28.38 67.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.991 -1.068 . . . . 3.76 109.054 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.519 ' HB2' ' CB ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -60.47 -33.75 73.03 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.155 -1.424 . . . . 2.19 107.155 178.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.54 ' CE ' HG12 ' A' ' 48' ' ' ILE . 7.0 ttt -81.03 -21.98 39.71 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.683 -0.858 . . . . 1.34 108.683 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 23' ' ' SER . 16.1 tt0 -78.69 -27.9 45.14 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.125 -0.984 . . . . 2.09 109.982 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -27.16 31.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.988 -1.07 . . . . 2.63 108.692 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.2 tp -71.53 -42.99 67.25 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.609 -0.682 . . . . 1.55 109.265 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.575 ' HB2' ' CD1' ' A' ' 28' ' ' ILE . 31.5 m-85 -92.24 -18.02 24.01 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.849 -0.741 . . . . 2.16 109.823 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 19' ' ' GLU . 3.1 m -67.86 -39.07 83.8 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.014 -1.054 . . . . 1.77 108.261 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -62.56 -24.81 67.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.516 -0.74 . . . . 2.88 109.312 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.522 ' CD2' ' HA ' ' A' ' 59' ' ' ALA . 31.4 m-85 -79.65 -29.67 41.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 2.36 109.209 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.474 ' HA3' ' CG ' ' A' ' 55' ' ' GLU . . . 176.44 137.82 2.73 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.145 -1.582 . . . . 0.84 109.145 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 26' ' ' GLY . 50.1 mtm-85 -43.0 105.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.401 -1.058 . . . . 4.7 109.362 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.575 ' CD1' ' HB2' ' A' ' 22' ' ' PHE . 22.7 mt -78.15 153.37 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.026 -1.046 . . . . 1.21 110.118 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.442 HG22 HG23 ' A' ' 30' ' ' THR . 9.6 mm -88.43 -73.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 109.1 -0.704 . . . . 1.34 109.1 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.442 HG23 HG22 ' A' ' 29' ' ' ILE . 25.1 p -125.67 127.9 46.98 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.602 -0.888 . . . . 1.6 108.602 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.542 ' HB2' ' CD1' ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.41 163.26 29.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 1.31 110.188 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.424 ' HB3' ' NH2' ' A' ' 32' ' ' ARG . 1.0 OUTLIER 175.55 152.58 0.14 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 4.04 110.015 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.513 HD11 ' CG ' ' A' ' 13' ' ' MET . 23.8 mt -102.2 121.59 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 1.35 109.332 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.576 ' O ' ' CB ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -84.3 103.39 13.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.351 -0.843 . . . . 2.78 109.11 179.393 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.527 HD22 ' N ' ' A' ' 44' ' ' GLY . 1.7 tm? -162.73 102.49 1.03 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.185 -1.043 . . . . 2.9 108.185 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.579 ' O ' ' HA ' ' A' ' 42' ' ' SER . 27.9 t70 -126.39 156.33 40.71 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.202 -1.561 . . . . 2.92 112.95 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.08 62.36 0.98 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.8 -1.188 . . . . 6.8 109.385 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -176.52 -42.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 3.61 110.127 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -132.41 17.23 4.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.992 -1.067 . . . . 4.38 110.178 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 41' ' ' VAL . . . -156.93 -106.36 0.24 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.09 -1.604 . . . . 3.48 109.09 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 40' ' ' GLY . 20.9 t -159.76 151.88 5.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.591 -1.263 . . . . 4.17 107.591 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 2.1 p -79.33 94.96 5.58 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.606 0.717 . . . . 2.66 109.257 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.576 ' CB ' ' O ' ' A' ' 34' ' ' LEU . 0.5 OUTLIER -77.74 -65.36 0.98 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.611 -0.681 . . . . 4.82 110.599 -179.047 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.527 ' N ' HD22 ' A' ' 35' ' ' LEU . . . 93.81 -13.55 67.21 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.159 -1.576 . . . . 1.24 109.159 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.623 HG11 ' CE2' ' A' ' 5' ' ' TYR . 5.3 t -85.99 171.49 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.306 -1.114 . . . . 1.47 109.189 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.534 ' O ' ' CE ' ' A' ' 18' ' ' MET . . . -149.39 119.06 1.0 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.509 -1.436 . . . . 0.81 109.509 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.51 ' O ' HG12 ' A' ' 48' ' ' ILE . 9.1 m-85 -89.55 162.88 15.45 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.224 -1.162 . . . . 2.35 109.646 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.542 ' CD1' ' HB2' ' A' ' 31' ' ' SER . 2.7 mm -150.22 118.9 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.403 -1.332 . . . . 1.23 107.403 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 3' ' ' ASN . 32.9 ttt-85 -104.02 103.15 12.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.678 -1.264 . . . . 3.49 110.687 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.529 ' CZ ' ' HB3' ' A' ' 22' ' ' PHE . 35.9 m-85 -79.71 156.68 27.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 2.24 108.895 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -65.1 -49.34 70.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.244 -0.91 . . . . 1.63 109.043 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.56 151.13 25.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.458 -0.776 . . . . 3.36 109.89 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.513 ' HG2' ' N ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -68.73 -25.16 64.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 4.07 109.209 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.513 ' N ' ' HG2' ' A' ' 53' ' ' ARG . 13.6 mm -70.8 -28.07 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 1.56 109.001 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' CG ' ' HA3' ' A' ' 26' ' ' GLY . 8.8 tp10 -74.03 -32.96 63.56 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.218 -0.926 . . . . 1.9 108.68 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.469 ' O ' HG13 ' A' ' 60' ' ' ILE . . . -83.28 -21.43 33.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.379 -0.825 . . . . 1.16 109.595 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.434 ' HG3' ' CE2' ' A' ' 79' ' ' PHE . 2.4 mt-10 -80.9 -55.29 4.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.126 -0.984 . . . . 1.89 108.78 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.29 -35.26 69.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 2.72 109.506 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.522 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . . . -74.79 -49.43 20.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.143 -0.973 . . . . 1.22 109.612 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.526 ' CD1' HD23 ' A' ' 4' ' ' LEU . 29.9 mt -47.07 -24.55 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 1.52 109.616 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -88.51 -34.36 17.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.057 -1.027 . . . . 3.33 110.344 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.449 ' O ' ' OH ' ' A' ' 25' ' ' TYR . . . -85.43 8.52 71.18 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.864 -1.16 . . . . 1.1 110.448 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.567 HD12 ' CZ ' ' A' ' 22' ' ' PHE . 13.9 mt -133.61 -46.76 0.81 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.943 -1.328 . . . . 1.45 110.128 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.521 ' N ' HG13 ' A' ' 77' ' ' VAL . 2.1 t30 -39.28 136.07 0.93 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.492 -0.755 . . . . 2.77 109.691 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.566 ' N ' ' CD1' ' A' ' 75' ' ' ILE . . . -107.99 -93.16 2.28 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.575 -1.41 . . . . 2.07 109.575 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -160.61 173.31 15.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.309 -1.112 . . . . 5.31 110.189 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.498 ' HA ' ' HG2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -160.81 102.35 1.3 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.424 -0.797 . . . . 6.96 109.474 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 69' ' ' LEU . 35.3 Cg_endo -77.2 -177.55 3.91 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.481 2.121 . . . . 4.87 110.303 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 68' ' ' PRO . 0.8 OUTLIER -42.6 -40.65 2.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.55 -0.719 . . . . 5.91 109.466 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 71' ' ' ALA . . . -86.89 44.05 3.28 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.628 -1.789 . . . . 3.67 108.628 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 70' ' ' GLY . . . -43.01 105.84 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.358 -1.083 . . . . 2.53 109.548 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.452 ' O ' ' HA2' ' A' ' 8' ' ' GLY . . . 171.82 -26.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.848 . . . . 2.64 110.317 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.603 ' N ' ' CD ' ' A' ' 74' ' ' PRO . 0.5 OUTLIER -85.09 -46.47 0.64 Allowed Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.081 -1.012 . . . . 3.4 111.668 -178.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 73' ' ' GLU . 36.3 Cg_endo -79.41 -177.59 3.98 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.646 2.23 . . . . 1.31 110.828 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 1.9 pt -97.2 157.53 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.532 -0.73 . . . . 1.68 110.286 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 43.9 m -159.72 82.91 0.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -0.835 . . . . 1.54 109.515 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.521 HG13 ' N ' ' A' ' 64' ' ' ASN . 3.5 p -83.15 84.65 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 1.32 109.639 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -110.46 150.84 28.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -0.86 . . . . 3.36 109.167 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.481 ' CZ ' HD11 ' A' ' 60' ' ' ILE . 28.9 m-85 -47.43 138.28 7.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.176 -0.953 . . . . 2.47 110.112 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.538 ' CB ' ' HB2' ' A' ' 5' ' ' TYR . . . -83.28 109.95 17.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.572 -0.705 . . . . 1.59 109.992 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 82' ' ' ASN . 26.1 t-20 -46.5 -30.2 2.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 5.07 108.759 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER 59.72 118.97 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 5.8 109.743 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.46 7.61 4.06 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.563 2.175 . . . . 5.42 110.592 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.2 m -133.59 18.62 3.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.951 . . . . 6.05 109.751 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.986 -1.007 . . . . 7.74 109.418 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.293 -0.632 . . . . 2.67 109.293 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.4 63.03 0.71 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.82 109.655 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.547 ' O ' HD23 ' A' ' 4' ' ' LEU . 22.8 p30 -86.15 167.82 14.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 1.42 109.225 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.89 HD21 ' HB1' ' A' ' 56' ' ' ALA . 24.2 mt -134.5 157.14 47.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.68 109.751 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.765 ' HB2' ' HB2' ' A' ' 80' ' ' ALA . 20.1 t80 -138.17 94.03 2.83 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.822 -0.807 . . . . 1.84 108.822 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.914 HG22 HG23 ' A' ' 77' ' ' VAL . 2.6 t -102.02 103.55 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.99 109.593 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.536 ' CA ' HG13 ' A' ' 45' ' ' VAL . 6.0 p -101.58 174.19 6.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.311 -0.868 . . . . 1.09 109.628 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 74' ' ' PRO . . . 77.4 30.97 52.9 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.519 -1.433 . . . . 1.17 109.519 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.5 HD13 ' HG2' ' A' ' 13' ' ' MET . 13.7 mt -90.02 155.74 47.09 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 1.24 109.645 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD2' ' SD ' ' A' ' 13' ' ' MET . 36.0 Cg_endo -77.78 171.48 17.29 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.658 2.239 . . . . 1.38 109.964 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -17.37 61.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.91 . . . . 3.97 109.509 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.6 p -79.67 -7.59 58.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.928 . . . . 1.72 109.46 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.688 ' HG3' HD11 ' A' ' 33' ' ' ILE . 3.2 tpt -61.71 103.92 0.38 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.933 . . . . 1.38 109.727 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.646 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -91.22 155.2 18.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 1.89 108.986 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.432 ' CD ' ' HG2' ' A' ' 32' ' ' ARG . 42.8 mt-30 -58.57 -56.3 23.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 2.88 109.694 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -28.38 67.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.991 -1.068 . . . . 3.35 109.054 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' HB2' ' CB ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -60.47 -33.75 73.03 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.155 -1.424 . . . . 2.19 107.155 178.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.567 ' CE ' HG12 ' A' ' 48' ' ' ILE . 7.0 ttt -81.03 -21.98 39.71 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 23' ' ' SER . 16.1 tt0 -78.69 -27.9 45.14 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.125 -0.984 . . . . 2.09 109.982 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -27.16 31.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.988 -1.07 . . . . 2.18 108.692 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.729 HD23 HD13 ' A' ' 63' ' ' LEU . 2.2 tp -71.53 -42.99 67.25 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.609 -0.682 . . . . 0.97 109.265 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 1.004 ' CB ' HD11 ' A' ' 28' ' ' ILE . 31.5 m-85 -92.24 -18.02 24.01 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.849 -0.741 . . . . 1.28 109.823 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 19' ' ' GLU . 3.1 m -67.86 -39.07 83.8 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.014 -1.054 . . . . 1.53 108.261 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -62.56 -24.81 67.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.516 -0.74 . . . . 2.51 109.312 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.529 ' CD2' ' HA ' ' A' ' 59' ' ' ALA . 31.4 m-85 -79.65 -29.67 41.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 1.51 109.209 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.482 ' HA3' ' CG ' ' A' ' 55' ' ' GLU . . . 176.44 137.82 2.73 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.145 -1.582 . . . . 0.84 109.145 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 26' ' ' GLY . 50.1 mtm-85 -43.0 105.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.401 -1.058 . . . . 4.1 109.362 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 1.004 HD11 ' CB ' ' A' ' 22' ' ' PHE . 22.7 mt -78.15 153.37 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.026 -1.046 . . . . 0.7 110.118 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 51' ' ' ASP . 9.6 mm -88.43 -73.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 109.1 -0.704 . . . . 0.81 109.1 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.486 HG23 HG22 ' A' ' 29' ' ' ILE . 25.1 p -125.67 127.9 46.98 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.602 -0.888 . . . . 0.96 108.602 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 1.006 ' HB2' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.41 163.26 29.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 1.09 110.188 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.439 ' HB3' ' NH2' ' A' ' 32' ' ' ARG . 1.0 OUTLIER 175.55 152.58 0.14 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 3.49 110.015 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.688 HD11 ' HG3' ' A' ' 13' ' ' MET . 23.8 mt -102.2 121.59 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.93 109.332 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.614 HD22 ' CD ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -84.3 103.39 13.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.351 -0.843 . . . . 2.25 109.11 179.393 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.71 HD13 ' O ' ' A' ' 35' ' ' LEU . 1.7 tm? -162.73 102.49 1.03 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.185 -1.043 . . . . 2.46 108.185 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.58 ' O ' ' HA ' ' A' ' 42' ' ' SER . 27.9 t70 -126.39 156.33 40.71 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.202 -1.561 . . . . 2.92 112.95 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.08 62.36 0.98 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.8 -1.188 . . . . 6.1 109.385 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -176.52 -42.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 3.28 110.127 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -132.41 17.23 4.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.992 -1.067 . . . . 3.99 110.178 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 41' ' ' VAL . . . -156.93 -106.36 0.24 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.09 -1.604 . . . . 3.31 109.09 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 40' ' ' GLY . 20.9 t -159.76 151.88 5.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.591 -1.263 . . . . 3.77 107.591 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 2.1 p -79.33 94.96 5.58 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.606 0.717 . . . . 2.46 109.257 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.614 ' CD ' HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -77.74 -65.36 0.98 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.611 -0.681 . . . . 4.31 110.599 -179.047 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.616 ' N ' HD23 ' A' ' 35' ' ' LEU . . . 93.81 -13.55 67.21 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.159 -1.576 . . . . 1.14 109.159 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.634 HG11 ' CE2' ' A' ' 5' ' ' TYR . 5.3 t -85.99 171.49 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.306 -1.114 . . . . 1.0 109.189 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.565 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -149.39 119.06 1.0 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.509 -1.436 . . . . 0.81 109.509 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.507 ' O ' HG12 ' A' ' 48' ' ' ILE . 9.1 m-85 -89.55 162.88 15.45 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.224 -1.162 . . . . 1.54 109.646 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.006 HD13 ' HB2' ' A' ' 31' ' ' SER . 2.7 mm -150.22 118.9 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.403 -1.332 . . . . 0.57 107.403 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' ASN . 32.9 ttt-85 -104.02 103.15 12.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.678 -1.264 . . . . 2.92 110.687 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.535 ' CZ ' ' HB3' ' A' ' 22' ' ' PHE . 35.9 m-85 -79.71 156.68 27.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 1.36 108.895 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.564 ' HB2' HD11 ' A' ' 29' ' ' ILE . 20.6 t0 -65.1 -49.34 70.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.244 -0.91 . . . . 1.63 109.043 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.56 151.13 25.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.458 -0.776 . . . . 2.88 109.89 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.516 ' HG2' ' N ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -68.73 -25.16 64.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 3.48 109.209 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.516 ' N ' ' HG2' ' A' ' 53' ' ' ARG . 13.6 mm -70.8 -28.07 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 1.07 109.001 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 50' ' ' PHE . 8.8 tp10 -74.03 -32.96 63.56 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.218 -0.926 . . . . 1.9 108.68 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.89 ' HB1' HD21 ' A' ' 4' ' ' LEU . . . -83.28 -21.43 33.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.379 -0.825 . . . . 0.61 109.595 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.46 ' HG3' ' CE2' ' A' ' 79' ' ' PHE . 2.4 mt-10 -80.9 -55.29 4.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.126 -0.984 . . . . 1.89 108.78 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.29 -35.26 69.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 2.72 109.506 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.529 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . . . -74.79 -49.43 20.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.143 -0.973 . . . . 0.69 109.612 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.818 HG23 ' O ' ' A' ' 77' ' ' VAL . 29.9 mt -47.07 -24.55 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.85 109.616 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -88.51 -34.36 17.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.057 -1.027 . . . . 2.95 110.344 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.43 8.52 71.18 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.864 -1.16 . . . . 0.98 110.448 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.729 HD13 HD23 ' A' ' 21' ' ' LEU . 13.9 mt -133.61 -46.76 0.81 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.943 -1.328 . . . . 0.93 110.128 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.775 ' HA ' HG12 ' A' ' 77' ' ' VAL . 8.9 t-20 -39.28 136.07 0.93 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.492 -0.755 . . . . 2.43 109.691 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.566 ' N ' ' CD1' ' A' ' 75' ' ' ILE . . . -107.99 -93.16 2.28 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.575 -1.41 . . . . 2.07 109.575 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -160.61 173.31 15.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.309 -1.112 . . . . 4.69 110.189 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.537 ' HA ' ' HG2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -160.81 102.35 1.3 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.424 -0.797 . . . . 6.53 109.474 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.502 ' HD3' ' HG3' ' A' ' 74' ' ' PRO . 35.3 Cg_endo -77.2 -177.55 3.91 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.481 2.121 . . . . 4.36 110.303 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 68' ' ' PRO . 0.8 OUTLIER -42.6 -40.65 2.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.55 -0.719 . . . . 5.57 109.466 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 71' ' ' ALA . . . -86.89 44.05 3.28 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.628 -1.789 . . . . 3.33 108.628 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -43.01 105.84 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.358 -1.083 . . . . 2.43 109.548 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 71' ' ' ALA . . . 171.82 -26.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.848 . . . . 2.23 110.317 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.603 ' N ' ' CD ' ' A' ' 74' ' ' PRO . 0.5 OUTLIER -85.09 -46.47 0.64 Allowed Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.081 -1.012 . . . . 3.4 111.668 -178.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 73' ' ' GLU . 36.3 Cg_endo -79.41 -177.59 3.98 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.646 2.23 . . . . 1.16 110.828 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 1.9 pt -97.2 157.53 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.532 -0.73 . . . . 1.07 110.286 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 43.9 m -159.72 82.91 0.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -0.835 . . . . 1.07 109.515 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.914 HG23 HG22 ' A' ' 6' ' ' VAL . 3.5 p -83.15 84.65 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.75 109.639 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -110.46 150.84 28.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -0.86 . . . . 3.0 109.167 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.517 ' CZ ' HD12 ' A' ' 60' ' ' ILE . 28.9 m-85 -47.43 138.28 7.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.176 -0.953 . . . . 1.62 110.112 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.765 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . -83.28 109.95 17.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.572 -0.705 . . . . 1.59 109.992 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 82' ' ' ASN . 26.1 t-20 -46.5 -30.2 2.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 4.32 108.759 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 81' ' ' ASN . 0.7 OUTLIER 59.72 118.97 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 5.07 109.743 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.46 7.61 4.06 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.563 2.175 . . . . 4.86 110.592 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.2 m -133.59 18.62 3.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.951 . . . . 5.77 109.751 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.986 -1.007 . . . . 7.18 109.418 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.293 -0.632 . . . . 2.67 109.293 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -116.4 63.03 0.71 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.93 . . . . 0.82 109.655 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.547 ' O ' HD23 ' A' ' 4' ' ' LEU . 22.8 p30 -86.15 167.82 14.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.166 -0.959 . . . . 1.42 109.225 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.89 HD21 ' HB1' ' A' ' 56' ' ' ALA . 24.2 mt -134.5 157.14 47.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -0.939 . . . . 0.68 109.751 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.765 ' HB2' ' HB2' ' A' ' 80' ' ' ALA . 20.1 t80 -138.17 94.03 2.83 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.822 -0.807 . . . . 1.84 108.822 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.914 HG22 HG23 ' A' ' 77' ' ' VAL . 2.6 t -102.02 103.55 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.19 -0.944 . . . . 0.99 109.593 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.536 ' CA ' HG13 ' A' ' 45' ' ' VAL . 6.0 p -101.58 174.19 6.08 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.311 -0.868 . . . . 1.09 109.628 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 74' ' ' PRO . . . 77.4 30.97 52.9 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.519 -1.433 . . . . 1.17 109.519 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.5 HD13 ' HG2' ' A' ' 13' ' ' MET . 13.7 mt -90.02 155.74 47.09 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 1.24 109.645 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD2' ' SD ' ' A' ' 13' ' ' MET . 36.0 Cg_endo -77.78 171.48 17.29 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.658 2.239 . . . . 1.38 109.964 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -17.37 61.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.91 . . . . 3.97 109.509 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.6 p -79.67 -7.59 58.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.216 -0.928 . . . . 1.72 109.46 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.688 ' HG3' HD11 ' A' ' 33' ' ' ILE . 3.2 tpt -61.71 103.92 0.38 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.208 -0.933 . . . . 1.38 109.727 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.646 ' C ' HD12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -91.22 155.2 18.75 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 1.89 108.986 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.432 ' CD ' ' HG2' ' A' ' 32' ' ' ARG . 12.0 mt-30 -58.57 -56.3 23.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 2.88 109.694 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -28.38 67.64 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.991 -1.068 . . . . 3.35 109.054 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' HB2' ' CB ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -60.47 -33.75 73.03 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.155 -1.424 . . . . 2.19 107.155 178.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.567 ' CE ' HG12 ' A' ' 48' ' ' ILE . 7.0 ttt -81.03 -21.98 39.71 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.538 ' O ' ' CB ' ' A' ' 23' ' ' SER . 16.1 tt0 -78.69 -27.9 45.14 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.125 -0.984 . . . . 2.09 109.982 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -27.16 31.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.988 -1.07 . . . . 2.18 108.692 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.729 HD23 HD13 ' A' ' 63' ' ' LEU . 2.2 tp -71.53 -42.99 67.25 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.609 -0.682 . . . . 0.97 109.265 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 1.004 ' CB ' HD11 ' A' ' 28' ' ' ILE . 31.5 m-85 -92.24 -18.02 24.01 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.849 -0.741 . . . . 1.28 109.823 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 19' ' ' GLU . 3.1 m -67.86 -39.07 83.8 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.014 -1.054 . . . . 1.53 108.261 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -62.56 -24.81 67.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.516 -0.74 . . . . 2.51 109.312 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.529 ' CD2' ' HA ' ' A' ' 59' ' ' ALA . 31.4 m-85 -79.65 -29.67 41.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.347 -0.846 . . . . 1.51 109.209 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.482 ' HA3' ' CG ' ' A' ' 55' ' ' GLU . . . 176.44 137.82 2.73 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.145 -1.582 . . . . 0.84 109.145 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 26' ' ' GLY . 50.1 mtm-85 -43.0 105.54 0.05 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.401 -1.058 . . . . 4.1 109.362 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 1.004 HD11 ' CB ' ' A' ' 22' ' ' PHE . 22.7 mt -78.15 153.37 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.026 -1.046 . . . . 0.7 110.118 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 51' ' ' ASP . 9.6 mm -88.43 -73.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 109.1 -0.704 . . . . 0.81 109.1 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.486 HG23 HG22 ' A' ' 29' ' ' ILE . 25.1 p -125.67 127.9 46.98 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.602 -0.888 . . . . 0.96 108.602 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 1.006 ' HB2' HD13 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -133.41 163.26 29.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -0.978 . . . . 1.09 110.188 -179.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.439 ' HB3' ' NH2' ' A' ' 32' ' ' ARG . 1.0 OUTLIER 175.55 152.58 0.14 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.436 -0.79 . . . . 3.49 110.015 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.688 HD11 ' HG3' ' A' ' 13' ' ' MET . 23.8 mt -102.2 121.59 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.93 109.332 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.614 HD22 ' CD ' ' A' ' 43' ' ' ARG . 0.3 OUTLIER -84.3 103.39 13.44 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.351 -0.843 . . . . 2.25 109.11 179.393 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.71 HD13 ' O ' ' A' ' 35' ' ' LEU . 1.7 tm? -162.73 102.49 1.03 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.185 -1.043 . . . . 2.46 108.185 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.58 ' O ' ' HA ' ' A' ' 42' ' ' SER . 27.9 t70 -126.39 156.33 40.71 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.202 -1.561 . . . . 2.92 112.95 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.08 62.36 0.98 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.8 -1.188 . . . . 6.1 109.385 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -176.52 -42.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 3.28 110.127 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -132.41 17.23 4.43 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.992 -1.067 . . . . 3.99 110.178 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.507 ' O ' ' CG2' ' A' ' 41' ' ' VAL . . . -156.93 -106.36 0.24 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.09 -1.604 . . . . 3.31 109.09 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 40' ' ' GLY . 20.9 t -159.76 151.88 5.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 107.591 -1.263 . . . . 3.77 107.591 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 36' ' ' ASP . 2.1 p -79.33 94.96 5.58 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 121.606 0.717 . . . . 2.46 109.257 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.614 ' CD ' HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -77.74 -65.36 0.98 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.611 -0.681 . . . . 4.31 110.599 -179.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.616 ' N ' HD23 ' A' ' 35' ' ' LEU . . . 93.81 -13.55 67.21 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.159 -1.576 . . . . 1.14 109.159 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.634 HG11 ' CE2' ' A' ' 5' ' ' TYR . 5.3 t -85.99 171.49 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.306 -1.114 . . . . 1.0 109.189 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.565 ' H ' HG12 ' A' ' 45' ' ' VAL . . . -149.39 119.06 1.0 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.509 -1.436 . . . . 0.81 109.509 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.507 ' O ' HG12 ' A' ' 48' ' ' ILE . 9.1 m-85 -89.55 162.88 15.45 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.224 -1.162 . . . . 1.54 109.646 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.006 HD13 ' HB2' ' A' ' 31' ' ' SER . 2.7 mm -150.22 118.9 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 107.403 -1.332 . . . . 0.57 107.403 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 3' ' ' ASN . 32.9 ttt-85 -104.02 103.15 12.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.678 -1.264 . . . . 2.92 110.687 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.535 ' CZ ' ' HB3' ' A' ' 22' ' ' PHE . 35.9 m-85 -79.71 156.68 27.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 1.36 108.895 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.564 ' HB2' HD11 ' A' ' 29' ' ' ILE . 20.6 t0 -65.1 -49.34 70.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.244 -0.91 . . . . 1.63 109.043 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.56 151.13 25.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.458 -0.776 . . . . 2.88 109.89 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.516 ' HG2' ' N ' ' A' ' 54' ' ' ILE . 0.0 OUTLIER -68.73 -25.16 64.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 3.48 109.209 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.516 ' N ' ' HG2' ' A' ' 53' ' ' ARG . 13.6 mm -70.8 -28.07 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 1.07 109.001 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' HB3' ' HB3' ' A' ' 50' ' ' PHE . 8.8 tp10 -74.03 -32.96 63.56 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.218 -0.926 . . . . 1.9 108.68 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.89 ' HB1' HD21 ' A' ' 4' ' ' LEU . . . -83.28 -21.43 33.29 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.379 -0.825 . . . . 0.61 109.595 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.46 ' HG3' ' CE2' ' A' ' 79' ' ' PHE . 2.4 mt-10 -80.9 -55.29 4.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.126 -0.984 . . . . 1.89 108.78 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -57.29 -35.26 69.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 2.72 109.506 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.529 ' HA ' ' CD2' ' A' ' 25' ' ' TYR . . . -74.79 -49.43 20.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.143 -0.973 . . . . 0.69 109.612 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.818 HG23 ' O ' ' A' ' 77' ' ' VAL . 29.9 mt -47.07 -24.55 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.85 109.616 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -88.51 -34.36 17.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.057 -1.027 . . . . 2.95 110.344 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.43 8.52 71.18 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.864 -1.16 . . . . 0.98 110.448 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.729 HD13 HD23 ' A' ' 21' ' ' LEU . 13.9 mt -133.61 -46.76 0.81 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.943 -1.328 . . . . 0.93 110.128 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.775 ' HA ' HG12 ' A' ' 77' ' ' VAL . 2.1 t30 -39.28 136.07 0.93 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.492 -0.755 . . . . 2.43 109.691 -179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.566 ' N ' ' CD1' ' A' ' 75' ' ' ILE . . . -107.99 -93.16 2.28 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.575 -1.41 . . . . 2.07 109.575 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -160.61 173.31 15.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.309 -1.112 . . . . 4.69 110.189 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.537 ' HA ' ' HG2' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -160.81 102.35 1.3 Allowed Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.424 -0.797 . . . . 6.53 109.474 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.502 ' HD3' ' HG3' ' A' ' 74' ' ' PRO . 35.3 Cg_endo -77.2 -177.55 3.91 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.481 2.121 . . . . 4.36 110.303 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 68' ' ' PRO . 0.8 OUTLIER -42.6 -40.65 2.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.55 -0.719 . . . . 5.57 109.466 -179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 71' ' ' ALA . . . -86.89 44.05 3.28 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.628 -1.789 . . . . 3.33 108.628 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.585 ' O ' ' HB2' ' A' ' 72' ' ' ALA . . . -43.01 105.84 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.358 -1.083 . . . . 2.43 109.548 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 71' ' ' ALA . . . 171.82 -26.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.344 -0.848 . . . . 2.23 110.317 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.603 ' N ' ' CD ' ' A' ' 74' ' ' PRO . 0.5 OUTLIER -85.09 -46.47 0.64 Allowed Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.081 -1.012 . . . . 3.4 111.668 -178.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 73' ' ' GLU . 36.3 Cg_endo -79.41 -177.59 3.98 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.646 2.23 . . . . 1.16 110.828 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 1.9 pt -97.2 157.53 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.532 -0.73 . . . . 1.07 110.286 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' VAL . 43.9 m -159.72 82.91 0.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -0.835 . . . . 1.07 109.515 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.914 HG23 HG22 ' A' ' 6' ' ' VAL . 3.5 p -83.15 84.65 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.2 -0.937 . . . . 0.75 109.639 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -110.46 150.84 28.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.324 -0.86 . . . . 3.0 109.167 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.517 ' CZ ' HD12 ' A' ' 60' ' ' ILE . 28.9 m-85 -47.43 138.28 7.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.176 -0.953 . . . . 1.62 110.112 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.765 ' HB2' ' HB2' ' A' ' 5' ' ' TYR . . . -83.28 109.95 17.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.572 -0.705 . . . . 1.59 109.992 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 82' ' ' ASN . 26.1 t-20 -46.5 -30.2 2.1 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.944 . . . . 4.32 108.759 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.453 ' O ' ' O ' ' A' ' 81' ' ' ASN . 0.3 OUTLIER 59.72 118.97 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 5.07 109.743 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.46 7.61 4.06 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.563 2.175 . . . . 4.86 110.592 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.2 m -133.59 18.62 3.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.179 -0.951 . . . . 5.77 109.751 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.986 -1.007 . . . . 7.18 109.418 179.888 . . . . . . . . 1 1 . 1 stop_ save_